FIELD: ophthalmology and oncology. SUBSTANCE: immunocompetent cells in peripheral blood serum are examined giving evaluations from calculation of T lymphocyte sub-populations CD3, CD4, CD8 and index of their ratios. When all characteristics deviate from their normal values, in particular, to form index equal to or lower than 1.0 or equal to or higher than 2.0, latent metastatic spread is stated. EFFECT: increased reliability of analysis. 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 1999 |
|
RU2157998C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2175242C1 |
METHOD FOR PREDICTING UVEITIC MELANOMA CLINICAL COURSE | 1999 |
|
RU2149404C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 1998 |
|
RU2146823C1 |
METHOD OF TREATING UVEAL MELANOMA | 2000 |
|
RU2169006C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
METHOD FOR PREDICTING CLINICAL DEVELOPMENT COURSE OF UVEAL MELANOMA | 2001 |
|
RU2192812C1 |
METHOD FOR SETTING DIFFERENTIAL DIAGNOSIS OF LEIOMYOMA AND IRIS MELANOMA | 2001 |
|
RU2199124C1 |
METHOD FOR PREDICTION OF UNFAVOURABLE COURSE OF UVEAL MELANOMA | 2018 |
|
RU2698797C1 |
Authors
Dates
2000-04-10—Published
1998-06-19—Filed